Dr. Harman Singh Thind – Rheumatologist in Mumbai

Dr. Harman Singh Thind is a Consultant Rheumatologist associated with Fortis Healthcare in Kalyan and Navi Mumbai. She specialises in the diagnosis and management of inflammatory arthritis, autoimmune disorders and connective tissue diseases. Her clinical interests include rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus and vasculitis.

Dr. Harman Singh Thind holds MBBS and MD qualifications and completed a Postdoctoral Fellowship in Rheumatology from Maharashtra University of Health Sciences in 2020. She received advanced training under rheumatologist Dr. Kaushik Bhojani and continued working with his specialist team, gaining experience in the evaluation of complex rheumatic diseases.

Her clinical practice includes the medical management of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. These inflammatory conditions may affect joints, tendons, the spine and other organs. Treatment requires identifying disease activity, assessing complications and choosing appropriate medication and monitoring strategies according to individual patient needs.

Dr. Thind also has expertise in systemic autoimmune diseases such as lupus, systemic sclerosis, Sjögren's syndrome, dermatomyositis and mixed connective tissue disease. These conditions can involve multiple organs and may require detailed investigations, long-term follow-up and coordination with other medical specialists.

Her professional profile identifies a special interest in autoimmune and rheumatic conditions associated with adverse obstetric history. Certain autoimmune disorders may affect pregnancy planning or contribute to pregnancy complications. Assessment and treatment in these situations require coordinated care between rheumatology, obstetrics and other relevant specialists.

Patients seeking a rheumatologist in Kalyan, Navi Mumbai or the wider Mumbai region may consult Dr. Harman Singh Thind for evaluation of persistent inflammatory joint symptoms, autoimmune disease concerns or complex connective tissue disorders. Treatment is based on clinical examination, relevant investigations, disease severity and individual health requirements.

Rheumatoid Arthritis Treatment

Rheumatoid arthritis is a chronic autoimmune disease that causes joint inflammation, pain, swelling and stiffness. Early diagnosis and appropriate treatment can reduce inflammation and help prevent joint damage. Management may include disease-modifying antirheumatic drugs, targeted therapies, physiotherapy and regular monitoring of disease activity.

Ankylosing Spondylitis Management

Ankylosing spondylitis is an inflammatory condition primarily affecting the spine and sacroiliac joints. Symptoms commonly include persistent back pain and morning stiffness. Treatment may involve physical exercise, anti-inflammatory medication and biologic therapy in selected patients to reduce inflammation and maintain mobility.

Psoriatic Arthritis Treatment

Psoriatic arthritis is an inflammatory joint disorder associated with psoriasis. It may cause joint pain, swelling, stiffness and inflammation around tendons. Management depends on the severity of joint and skin involvement and may include anti-inflammatory medicines, disease-modifying drugs, biologic therapies and rehabilitation.

Systemic Lupus Erythematosus Treatment

Systemic Lupus Erythematosus is an autoimmune disease that can affect the joints, skin, kidneys, blood cells and other organs. Treatment depends on organ involvement and disease severity. Management may include hydroxychloroquine, corticosteroids, immunosuppressive medicines and long-term monitoring for complications.

Vasculitis Management

Vasculitis refers to a group of disorders characterised by inflammation of blood vessels. Symptoms and complications depend on the vessels and organs affected. Evaluation may involve blood tests, imaging or biopsy. Treatment often requires immunosuppressive medication and careful monitoring of organ function.

Systemic Sclerosis Management

Systemic sclerosis is an autoimmune connective tissue disease that can cause skin thickening, vascular abnormalities and internal organ involvement. Treatment focuses on specific symptoms and complications. Monitoring may include assessment of lung, heart, kidney and gastrointestinal function, depending on the patient's clinical condition.

Sjögren's Syndrome Treatment

Sjögren's syndrome is an autoimmune disorder commonly associated with dry eyes and dry mouth. Some patients also develop joint symptoms or systemic complications. Treatment depends on the organs affected and may include symptom-relieving therapies, dental and eye care, and medication for inflammatory manifestations.

Dermatomyositis Treatment

Dermatomyositis is an inflammatory disease that may cause muscle weakness and characteristic skin changes. Evaluation can include muscle enzyme testing, imaging and other investigations. Treatment often involves corticosteroids or other immunosuppressive medicines, with rehabilitation and monitoring for associated complications.

Mixed Connective Tissue Disease Management

Mixed connective tissue disease is an autoimmune condition with overlapping features of lupus, systemic sclerosis and inflammatory muscle disease. Symptoms may involve joints, muscles, skin and internal organs. Treatment depends on the particular manifestations and may require medication, symptom management and ongoing monitoring.

Sarcoidosis Assessment

Sarcoidosis is an inflammatory disease that can affect the lungs, lymph nodes, skin, eyes and other organs. Some patients require observation alone, while others need medication to control inflammation. Assessment includes determining the extent of organ involvement and excluding other possible causes.

Autoimmune Disease and Pregnancy Planning

Women with autoimmune rheumatic disorders may require specialist evaluation before and during pregnancy. Disease activity, medication safety and previous pregnancy complications are important considerations. Rheumatology and obstetric teams work together to assess risks and develop an individualised management plan for maternal and fetal health.